Entera Bio Ltd (ENTX)

Etorro trading 970x250

About Entera Bio Ltd

Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company’s lead product candidates include the EB612, an oral parathyroid hormone product candidate, which is in Phase 2 clinical trials for the treatment of hypoparathyroidism; and EB613 that is in Phase 2 clinical trials for the treatment of osteoporosis. It is also developing EB613 for the treatment of non-union fractures. The company has a research collaboration and license agreement with the Amgen Inc. for the development and discovery of clinical candidates in the field of inflammatory disease and other serious illnesses. Entera Bio Ltd. was incorporated in 2009 and is based in Jerusalem, Israel. Address: Kiryat Hadassah Minrav Building, Jerusalem, Israel, 9122002

Entera Bio Ltd News and around…

Latest news about Entera Bio Ltd (ENTX) common stock and company :

7 Biotech Penny Stocks With Huge Catalysts Coming in 2022
14 Oct, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips With a new year fast approaching, these biotech penny stocks may benefit from the shifting winds in the broader healthcare market. The post 7 Biotech Penny Stocks With Huge Catalysts Coming in 2022 appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar

Entera Bio's Formulated Human Parathyroid Hormone Shows Encouraging BMD Data
06 Oct, 2021 FinancialContent

Entera Bio Ltd(NASDAQ: ENTX) haspresented the 6-month bone mineral density (BMD) datafrom its Phase 2 trial of ...

Entera Bio Presents Positive Phase 2 6-Month Bone Mineral Density Data for Oral PTH Formulation at Late Breaker ASBMR Conference Session
06 Oct, 2021 Yahoo! Finance

Increases in lumbar spine, femoral neck and total hip BMD demonstrated with EB613 Linear Dose Responses Seen in Biomarker and Bone Mineral Density Data Pivotal Phase 3 registration study expected to commence 2022 BOSTON and JERUSALEM, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of orally delivered large molecule therapeutics, presented the 6-month bone mineral density (BMD) data from its completed Phase 2 clinical trial of EB613, an oral formulat

The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO
01 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA ...

Entera Bio (NASDAQ:ENTX) Is In A Strong Position To Grow Its Business
17 Sep, 2021 Yahoo! Finance

We can readily understand why investors are attracted to unprofitable companies. Indeed, Entera Bio ( NASDAQ:ENTX...

Entera Bio Selected for Late Breaking Oral Presentation of Phase 2 6-Month Osteoporosis Data at ASBMR 2021 Annual Meeting
01 Sep, 2021 FinancialContent
Entera Bio to Conduct Annual Shareholders Meeting on October 4, 2021
23 Aug, 2021 FinancialContent
Entera Bio to Present at H.C. Wainwright 23rd Annual Global Investment Conference
23 Aug, 2021 FinancialContent
Relative Strength Alert For Entera Bio
20 Aug, 2021 FinancialContent

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100..

New Strong Sell Stocks for August 19th
19 Aug, 2021 Yahoo! Finance

ALIM, BEEM, CDR, ENTX, and IDEX have been added to the Zacks Rank #5 (Strong Sell) List on August 19, 2021.

Entera Bio Reports Second Quarter 2021 Financial Results and Provides Clinical Updates
16 Aug, 2021 FinancialContent
Earnings Scheduled For August 16, 2021
16 Aug, 2021 FinancialContent

Companies Reporting Before The Bell • Entera Bio (NASDAQ:ENTX) is likely to report earnings for its second ...

Entera Bio to Report Business and Financial Results for the Quarter ended June 30, 2021, on August 16, 2021
13 Aug, 2021 FinancialContent
10 Biotech Penny Stocks to Buy According to Reddit
06 Aug, 2021 Yahoo! Finance

In this article, we discuss the 10 biotech penny stocks to buy according to Reddit. If you want to skip our detailed analysis of these stocks, go directly to the 5 Biotech Penny Stocks to Buy According to Reddit. Innovation and advancements in science and technology over the past few decades have transformed the field […]

Entera Bio to Present Phase 2 EB613 Oral PTH Osteoporosis Treatment 3-Month Findings at the American Society for Bone and Mineral Research Annual Meeting
02 Aug, 2021 FinancialContent
First Week of ENTX February 2022 Options Trading
09 Jul, 2021 FinancialContent

Investors in Entera Bio Ltd (ENTX) saw new options begin trading this week, for the February 2022 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 224 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration..

Neurodegenerative Disease And Cancer Stocks Among Top Biotech Gainers In 2021
04 Jul, 2021 FinancialContent

Biotech stocks underperformed the broader market in the first half of 2021, with the iShares Nasdaq Biotechnology ETF IBB advancing about 8% year-to-date compared to the roughly 14% gain for the S&P 500 Index.

Neurodegenerative Disease, Cancer Stocks Among Top Biotech Gainers In 2021
04 Jul, 2021 FinancialContent

Biotech stocks underperformed the broader market in the first half of 2021, with theiShares Nasdaq Biotechnology ETF (NASDAQ: IBB) ...

Entera Bio to Conduct Conference Call on June 30 to Discuss Phase 2 Results for EB613 Positioned to be the First Oral Bone-Building Agent for the Treatment of Osteoporosis
28 Jun, 2021 FinancialContent
Entera Bio Stock Could More Than Double From Here, Says Analyst
25 Jun, 2021 Yahoo! Finance

In the biotech space, big announcements often precede big share price movements; both were on tap for Entera Bio (ENTX) on Wednesday. Entera shares took off after the company provided an update from the placebo-controlled, double blind Phase 2 trial of EB613, Entera’s drug candidate for the treatment of osteoporosis. Following 6 months of treatment, the study achieved its key endpoints. Participants who took a 2.5 mg dose of EB613 displayed meaningful dose-related increases in bone mineral densi

Top Stocks To Buy This Week? 4 Health Care Stocks To Watch
24 Jun, 2021 FinancialContent
Entera (ENTX) Up on Positive Results From Osteoporosis Drug
24 Jun, 2021 Yahoo! Finance

Entera (ENTX) gains on positive results from a mid-stage study on its osteoporosis candidate at six months.

The Daily Biotech Pulse: Lilly Spikes On Alzheimer's Drug Regulatory Filing Plan, Applied Genetics, Arcus Issue Data Readouts, Adcom Test Awaits Incyte, Monte Rosa Prices IPO
24 Jun, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
24 Jun, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Welcome to another busy day of trading, investor! We're starting the day off with a look at the biggest pre-market stock movers for Thursday. The post Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now It doesn’t matter if you have $500 in savings or $5 million. Do this now. Top Stock Picker Reveals His Next Potential 500% Winner

45 Biggest Movers From Yesterday
24 Jun, 2021 FinancialContent

Gainers Entera Bio Ltd. (NASDAQ: ENTX) shares surged 44.8% to close at $6.50 on Wednesday after the company reported topline ...

Entera Bio Surging on Drug Development; Will the Rise Continue?
24 Jun, 2021 Yahoo! Finance

Entera Bio Ltd.'s (ENTX) share price surged 44.8% to close at $6.50 on June 23. Entera Bio is a developer of orally delivered large molecule and biologic therapeutics. The company continues to witness developments and improvements in drug research in 2021, winning the confidence of its investors and seeing its share price rise to a new high. With a market capital of 154.5 million, the share price of Entera Bio has almost tripled recently. It has skyrocketed 507.5% and 233.3% over the past six mo

Where Might Entera Bio Stock End Up After Rallying Wednesday
23 Jun, 2021 FinancialContent

Entera Bio Ltd(NASDAQ: ENTX) shares rallied higher Wednesday after the company announced it saw positive results from its final ...

ENTX Stock: The Huge FDA News Sending Entera Bio Soaring
23 Jun, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Today, investors in ENTX stock are seeing gains of approximately 40% as the company announced results from one of its clinical trials. The post ENTX Stock: The Huge FDA News Sending Entera Bio Soaring appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now It doesn’t matter if you have $500 in savings or $5 million. Do this now. Top Stock Picker Reveals His Next Potential 500% Winner

Mid-Afternoon Market Update: Patterson Companies Drops On Earnings Miss; Entera Bio Shares Gain
23 Jun, 2021 FinancialContent

Toward the end of trading Wednesday, the Dow traded down 0.08% to 33,918.98 while the NASDAQ rose 0.16% to 14,276.41. The S&P also ...

Nasdaq Notches Intraday High, SPX Eyes Third-Straight Win
23 Jun, 2021 FinancialContent

The Dow Jones Industrial Average is modestly lower this afternoon, walking back this morning's gains to register a 19-point drop.

Entera Bio Ltd (ENTX) is a NASDAQ Common Stock listed in , ,

970x250